Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prosper Channel Lifescience India (PCLI) is a multinational pharmaceutical and biopharmaceutical company headquartered in New Delhi, India. Established in November 2005, the company specializes in importing, marketing, and distributing a broad range of vital lifesaving biological products and medicines, including immunoglobulins, vaccines, and blood products. PCLI also provides regulatory services and clinical trial management to support international clients in registering and launching products in the Indian market. Its commercial portfolio includes Hepatitis B Immunoglobulin, Human Rabies Immunoglobulin, Anti Rabies Vaccine, and various plasma-derived therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prosper channel Lifescience India.